Very Late Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Case Report and Literature Review

I. R. Schreibman, P. Bejarano, E. J. Martinez, A. Regev

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) recurs in 10% to 60% of the patients after liver transplantation (OLT) and is associated with increased mortality. The average time to recurrence ranges from 1 to 2 years following OLT, and the median survival from the time of diagnosis is about 1 year. We report a case of a 69-year-old man who underwent OLT for hepatitis C virus-related cirrhosis with HCC, and was diagnosed with recurrent HCC 6.5 years after OLT. Biopsies from the initial and recurrent tumors showed a well-differentiated HCC with foci of clear cell pattern. The patient was still alive and asymptomatic 32 months after the diagnosis despite extensive tumor burden. He expired 9 years, 9 months after OLT and 3 years, 2 months after the detection of recurrence. In conclusion, HCC may recur more than 6 years after OLT and may exhibit an indolent course. This case illustrates the highly variable rate of tumor growth and progression post-OLT. The impact of this information on the need for long-term surveillance for recurrent HCC post-OLT remains to be determined.

Original languageEnglish
Pages (from-to)3140-3143
Number of pages4
JournalTransplantation Proceedings
Volume38
Issue number9
DOIs
StatePublished - Nov 1 2006

Fingerprint

Liver Transplantation
Hepatocellular Carcinoma
Recurrence
Tumor Burden
Hepacivirus
Neoplasms
Fibrosis
Biopsy
Survival
Mortality
Growth

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Very Late Recurrence of Hepatocellular Carcinoma After Liver Transplantation : Case Report and Literature Review. / Schreibman, I. R.; Bejarano, P.; Martinez, E. J.; Regev, A.

In: Transplantation Proceedings, Vol. 38, No. 9, 01.11.2006, p. 3140-3143.

Research output: Contribution to journalArticle

Schreibman, I. R. ; Bejarano, P. ; Martinez, E. J. ; Regev, A. / Very Late Recurrence of Hepatocellular Carcinoma After Liver Transplantation : Case Report and Literature Review. In: Transplantation Proceedings. 2006 ; Vol. 38, No. 9. pp. 3140-3143.
@article{cd108622367f48fabf601c3c9bd342f0,
title = "Very Late Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Case Report and Literature Review",
abstract = "Hepatocellular carcinoma (HCC) recurs in 10{\%} to 60{\%} of the patients after liver transplantation (OLT) and is associated with increased mortality. The average time to recurrence ranges from 1 to 2 years following OLT, and the median survival from the time of diagnosis is about 1 year. We report a case of a 69-year-old man who underwent OLT for hepatitis C virus-related cirrhosis with HCC, and was diagnosed with recurrent HCC 6.5 years after OLT. Biopsies from the initial and recurrent tumors showed a well-differentiated HCC with foci of clear cell pattern. The patient was still alive and asymptomatic 32 months after the diagnosis despite extensive tumor burden. He expired 9 years, 9 months after OLT and 3 years, 2 months after the detection of recurrence. In conclusion, HCC may recur more than 6 years after OLT and may exhibit an indolent course. This case illustrates the highly variable rate of tumor growth and progression post-OLT. The impact of this information on the need for long-term surveillance for recurrent HCC post-OLT remains to be determined.",
author = "Schreibman, {I. R.} and P. Bejarano and Martinez, {E. J.} and A. Regev",
year = "2006",
month = "11",
day = "1",
doi = "10.1016/j.transproceed.2006.08.095",
language = "English",
volume = "38",
pages = "3140--3143",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "9",

}

TY - JOUR

T1 - Very Late Recurrence of Hepatocellular Carcinoma After Liver Transplantation

T2 - Case Report and Literature Review

AU - Schreibman, I. R.

AU - Bejarano, P.

AU - Martinez, E. J.

AU - Regev, A.

PY - 2006/11/1

Y1 - 2006/11/1

N2 - Hepatocellular carcinoma (HCC) recurs in 10% to 60% of the patients after liver transplantation (OLT) and is associated with increased mortality. The average time to recurrence ranges from 1 to 2 years following OLT, and the median survival from the time of diagnosis is about 1 year. We report a case of a 69-year-old man who underwent OLT for hepatitis C virus-related cirrhosis with HCC, and was diagnosed with recurrent HCC 6.5 years after OLT. Biopsies from the initial and recurrent tumors showed a well-differentiated HCC with foci of clear cell pattern. The patient was still alive and asymptomatic 32 months after the diagnosis despite extensive tumor burden. He expired 9 years, 9 months after OLT and 3 years, 2 months after the detection of recurrence. In conclusion, HCC may recur more than 6 years after OLT and may exhibit an indolent course. This case illustrates the highly variable rate of tumor growth and progression post-OLT. The impact of this information on the need for long-term surveillance for recurrent HCC post-OLT remains to be determined.

AB - Hepatocellular carcinoma (HCC) recurs in 10% to 60% of the patients after liver transplantation (OLT) and is associated with increased mortality. The average time to recurrence ranges from 1 to 2 years following OLT, and the median survival from the time of diagnosis is about 1 year. We report a case of a 69-year-old man who underwent OLT for hepatitis C virus-related cirrhosis with HCC, and was diagnosed with recurrent HCC 6.5 years after OLT. Biopsies from the initial and recurrent tumors showed a well-differentiated HCC with foci of clear cell pattern. The patient was still alive and asymptomatic 32 months after the diagnosis despite extensive tumor burden. He expired 9 years, 9 months after OLT and 3 years, 2 months after the detection of recurrence. In conclusion, HCC may recur more than 6 years after OLT and may exhibit an indolent course. This case illustrates the highly variable rate of tumor growth and progression post-OLT. The impact of this information on the need for long-term surveillance for recurrent HCC post-OLT remains to be determined.

UR - http://www.scopus.com/inward/record.url?scp=33750965911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750965911&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2006.08.095

DO - 10.1016/j.transproceed.2006.08.095

M3 - Article

C2 - 17112921

AN - SCOPUS:33750965911

VL - 38

SP - 3140

EP - 3143

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 9

ER -